🇺🇸 FDA
Pipeline program

Descartes-08

HELIOS-001

Phase 2 small_molecule active

Quick answer

Descartes-08 for Childhood-onset Systemic Lupus Erythematous is a Phase 2 program (small_molecule) at Cartesian Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Cartesian Therapeutics
Indication
Childhood-onset Systemic Lupus Erythematous
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials